The CERVANTES team is pleased to announce the successful initiation of the trial in Prague, Czech Republic, in preparation for the recruitment of the first patient to the study.
The first Site Initiation Visit to General University Hospital in Prague, Czech Republic, was successfully completed on 15.6.2022, under the leadership of Prof. David Cibula. This event is an important milestone of the project, marking the readiness to promptly begin the recruitment of patients. An extended total of 5 clinical investigational sites have been confirmed and are scheduled to be activated very soon.
